| 000 | 01870 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516140215.0 | ||
| 264 | 0 | _c20141009 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a2476-762X | ||
| 024 | 7 |
_a10.7314/apjcp.2012.13.12.6463 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJiang, Xiao-Liang | |
| 245 | 0 | 0 |
_aTargeting renal cell carcinoma with gambogic acid in combination with sunitinib in vitro and in vivo. _h[electronic resource] |
| 260 |
_bAsian Pacific journal of cancer prevention : APJCP _c2012 |
||
| 300 |
_a6463-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aG1 Phase _xdrug effects |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNF-kappa B _xgenetics |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aXanthones _xadministration & dosage |
| 650 | 0 | 4 |
_aXenograft Model Antitumor Assays _xmethods |
| 700 | 1 | _aZhang, Yao | |
| 700 | 1 | _aLuo, Chun-Li | |
| 700 | 1 | _aWu, Xiao-Hou | |
| 773 | 0 |
_tAsian Pacific journal of cancer prevention : APJCP _gvol. 13 _gno. 12 _gp. 6463-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7314/apjcp.2012.13.12.6463 _zAvailable from publisher's website |
| 999 |
_c22556866 _d22556866 |
||